These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 2863752)

  • 1. Clinical and pathological features and laboratory confirmation of Creutzfeldt-Jakob disease in a recipient of pituitary-derived human growth hormone.
    Gibbs CJ; Joy A; Heffner R; Franko M; Miyazaki M; Asher DM; Parisi JE; Brown PW; Gajdusek DC
    N Engl J Med; 1985 Sep; 313(12):734-8. PubMed ID: 2863752
    [No Abstract]   [Full Text] [Related]  

  • 2. Potential epidemic of Creutzfeldt-Jakob disease from human growth hormone therapy.
    Brown P; Gajdusek DC; Gibbs CJ; Asher DM
    N Engl J Med; 1985 Sep; 313(12):728-31. PubMed ID: 3929089
    [No Abstract]   [Full Text] [Related]  

  • 3. [Non-conventional central nervous system agents].
    Chippaux A
    Bull Soc Pathol Exot Filiales; 1987; 80(5):727-36. PubMed ID: 2897253
    [No Abstract]   [Full Text] [Related]  

  • 4. [Prions, Jakob-Creutzfeldt disease and human growth hormone].
    González PM
    Rev Hosp Clin Fac Med Sao Paulo; 1986; 41(5):207-9. PubMed ID: 3296112
    [No Abstract]   [Full Text] [Related]  

  • 5. Creutzfeldt-Jakob disease in a young adult with idiopathic hypopituitarism. Possible relation to the administration of cadaveric human growth hormone.
    Koch TK; Berg BO; De Armond SJ; Gravina RF
    N Engl J Med; 1985 Sep; 313(12):731-3. PubMed ID: 3897861
    [No Abstract]   [Full Text] [Related]  

  • 6. Creutzfeldt-Jakob disease prion proteins in human brains.
    Bockman JM; Kingsbury DT; McKinley MP; Bendheim PE; Prusiner SB
    N Engl J Med; 1985 Jan; 312(2):73-8. PubMed ID: 3917302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A patient with Creutzfeldt-Jakob disease following treatment with human growth hormone].
    Roos RA; Wintzen AR; Will RG; Ironside JW; van Duinen SG
    Ned Tijdschr Geneeskd; 1996 Jun; 140(22):1190-3. PubMed ID: 8692356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experimental Creutzfeldt-Jakob disease: light microscopic, immunohistochemical and ultrastructural studies of the Fujisaki strain of Creutzfeldt-Jakob disease virus in NIH Swiss mice.
    Liberski PP; Yanagihara R; Gibbs CJ; Gajdusek DC
    Neuropatol Pol; 1991; 29(1-2):1-17. PubMed ID: 1813811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selection of specific strains in iatrogenic Creutzfeldt-Jakob disease.
    Deslys JP; Lasmézas C; Dormont D
    Lancet; 1994 Apr; 343(8901):848-9. PubMed ID: 7908088
    [No Abstract]   [Full Text] [Related]  

  • 10. [Creutzfeldt-Jakob disease in 4 children treated with growth hormone].
    Billette de Villemeur T; Gourmelen M; Beauvais P; Rodriguez D; Vaudour G; Deslys JP; Dormont D; Richard P; Richardet JM
    Rev Neurol (Paris); 1992; 148(5):328-34. PubMed ID: 1448646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human growth hormone and Creutzfeldt-Jakob disease.
    Bol Asoc Med P R; 1988 Jul; 80(7):253-7. PubMed ID: 3048299
    [No Abstract]   [Full Text] [Related]  

  • 12. A new case of Creutzfeldt-Jakob disease associated with human growth hormone therapy in New Zealand.
    Croxson M; Brown P; Synek B; Harrington MG; Frith R; Clover G; Wilson J; Gajdusek DC
    Neurology; 1988 Jul; 38(7):1128-30. PubMed ID: 3290702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prion protein deposits match magnetic resonance imaging signal abnormalities in Creutzfeldt-Jakob disease.
    Haïk S; Dormont D; Faucheux BA; Marsault C; Hauw JJ
    Ann Neurol; 2002 Jun; 51(6):797-9. PubMed ID: 12112094
    [No Abstract]   [Full Text] [Related]  

  • 14. An overview of Creutzfeldt-Jakob disease associated with the use of human pituitary growth hormone.
    Will RG
    Dev Biol Stand; 1991; 75():85-6. PubMed ID: 1794632
    [No Abstract]   [Full Text] [Related]  

  • 15. Potential epidemic of Creutzfeldt-Jakob disease from human growth hormone therapy.
    Fisman M
    N Engl J Med; 1986 Apr; 314(15):987-8. PubMed ID: 3515181
    [No Abstract]   [Full Text] [Related]  

  • 16. Creutzfeldt-Jakob disease (CJD) of a short duration with prion protein (PrP) plaques.
    Liberski PP; Kwieciński H; Barcikowska M; Mirecka B; Kulczycki J; Kida E; Brown P; Gajdusek DC
    Patol Pol; 1991; 42(4):115-8. PubMed ID: 1845486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Creutzfeldt-Jakob disease prion proteins in human brains.
    Manuelidis L
    N Engl J Med; 1985 Jun; 312(25):1643-5. PubMed ID: 3923350
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical neuropathology of Creutzfeldt-Jakob disease.
    Bugiani O; Giaccone G; Tagliavini F
    Funct Neurol; 1997; 12(3-4):165-6. PubMed ID: 9218971
    [No Abstract]   [Full Text] [Related]  

  • 19. [Biological aspects of Creutzfeldt-Jakob disease related to the extractive growth hormone].
    Deslys JP
    Pathol Biol (Paris); 1995 Feb; 43(2):97-103. PubMed ID: 7777386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hypophyseal growth hormone and Creutzfeldt-Jakob disease in The Netherlands. Ad hoc Commission Creutzfeldt-Jakob-disease of the Dutch Growth Foundation].
    Rikken B; Massa GG; Wit JM; van den Brande JL
    Ned Tijdschr Geneeskd; 1996 Jun; 140(22):1163-5. PubMed ID: 8692348
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.